Molly Quinn, MD, FACOG

Board Certified Reproductive Endocrinologist

Dr. Molly Quinn of HRC Fertility Pasadena and the USC Fertility Center

Dr. Molly Quinn received her medical degree from David Geffen School of Medicine at UCLA and did her specialty and subspecialty training at University of California San Francisco (UCSF).  She specializes in reproductive endocrinology & infertility.

Her research interests include optimizing pregnancy outcomes subsequent to assisted reproduction, the role of the reproductive laboratory in improving in vitro fertilization (IVF) outcomes, and the long-term safety of IVF and related treatments.

 

 

Upcoming Events


  • Coming soon.
  • Undergraduate: Stanford University
  • Medical School: David Geffen School of Medicine, University of California, Los Angeles
  • Internship/Residency: Obstetrics and Gynecology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco
  • Fellowship: Reproductive Endocrinology and Infertility Fellowship Training, Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology, University of California San Francisco
  • Advanced Training: Clinical Research (ATCR) Certificate Program, Department of Epidemiology and Biostatics, University of California San Francisco; Clinical Research/Reproductive Scientist Training Program (CREST) ASRM/NICHD/DUKE
  • 2021 – Top Doctors, Los Angeles Magazine
  • 2020, 2021 – SuperDoctors Southern California Rising Star
  • 2019 – Obstetrics and Gynecology: Top 10% Peer Reviewer
  • 2017 – Society for Assisted Reproductive Technology Prize Paper
  • 2017 – University of California San Francisco Medical Student Teaching Award
  • 2017 – Pacific Coast Reproductive Society In-Training Travel Grant
  • 2016, 2017 – American Society for Reproductive Medicine In-Training Travel Grant
  • 2016 – Vivere Health Scientific Advisory Board ASRM Travel Grant
  • 2015 – Vivere Health Scientific Advisory Board Research Grant
  • 2015 – University of California San Francisco Medical Student Award for Best Resident Teacher
  • 2014 – San Francisco General Hospital Medical Student Appreciation for Resident Teacher
  • 2014 – Androgen Excess and PCOS Society Young Researcher Travel Award
  • 2014 – Clinical and Translational Science Institute (CTSI) Resident Research Travel Award
  • 2013 – North American Menopause Society/Pfizer Medical Resident Reporter Award
  • 2012 – Clinical and Translational Science Institute (CTSI) Resident Research Funding Award
  • 2010-2011 – Apha Omega Alpha (AOA), Delta Chapter President
  • 2011 – American Medical Women’s Association Janet M. Glasgow Memorial Award for Top Graduating Female Medical Student
  • 2011 – William Dignam Award for Excellence in Obstetrics and Gynecology
  • 2011 – Award of Excellence: UCLA Department of Medicine Clinical Faculty Association
  • 2008 – Internal Medicine Chief’s Fellowship Research Grant, UCLA
  • 2007 – Phi Beta Kappa, Stanford University
  • 2003 – Edmondson Fellowship/NIH-Heart, Lung and Blood Institute Scholar

Dr. Quinn’s research interests include optimizing pregnancy outcomes subsequent to assisted reproduction, the role of the reproductive laboratory in improving in vitro fertilization (IVF) outcomes, and the long-term safety of IVF and related treatments.

  • 2021 – Present: Assistant Clinical Professor. Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Southern California/Keck School of Medicine
  • 2018-2021: Health Sciences Assistant Clinical Professor. Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of California Los Angeles.
  • Fellow of the American College of Obstetrics and Gynecology
  • Society for Reproductive Endocrinology and Infertility (SREI), Chair Resident and Medical Student Education Committee
  • American Society for Reproductive Medicine, member

Peer-Reviewed Publications

  1. Quinn MM, Marsh P, Ribeiro S, Simbulan RK, Hickman C, Berntsen J, Rosen MP. Aneuploidy rates and morphokinetic parameters of embryos cultured in distinct culture media: A sibling oocyte study. Hum Reprod 2021; in press. 
  2. Mehr H, Jackson-Bey T, Vu M, Lee V, Herndon C, Ho J, Aghajanova L, Quinn MM. We are here for you: infertility clinic communication during the first wave of the COVID-19 pandemic. J Assist Reprod Genet 2021; in press
  3. Shapiro A, Kroener L, Quinn MM. Expanded carrier screening for recessively-inherited disorders: Economic burden and factors in decision-making when one individual in a couple is identified as a carrier. J Assist Reprod Genet 2021; in press
  4. Huang D, Jaswa E, Kao C-N, Quinn M, Cedars M, Huddleston H. Predictors of adequate physical activity within a multiethnic polycystic ovary syndrome patient population: a cross-sectional assessment. BMC Women’s Health 2021, in press.
  5. Riestenberg CK, Mok T, Ong JR, Platt LD, Han CS, Quinn MM. Sonographic abnormalities in pregnancies conceived following IVF with and without preimplantation genetic testing for aneuploidy (PGT-A). J Assist Reprod Genet 2021; in press.
  6. Riestenberg C, Kroener L, Quinn MM, Ching K, Ambartsumyan G. Routine endometrial receptivity array in first embryo transfer cycles does not improve live birth rate Fertil Steril 2020; in press.
  7. Riestenberg C, Quinn M, Akopians A, Danzer H, Ghadir S, Surrey M, Kroener L. Endometrial compaction does not predict live birth rate in single euploid frozen embryo transfer cycles J Assist Reprod Genet 2020; in press.
  8. Kaing A, Rosen MP, Quinn MM. Perceptions, motivations, and decision regret surrounding preimplantation genetic testing for aneuploidy Hum Reprod 2020; 35(9):2047-57.
  9. Han YM, Grenert JP, Wiita AP, Quinn M, Fujimoto VY, Rabban JT. Prevalence of partial hydatidiform mole in products of conception from gestations with fetal triploidy merits reflex genotype testing independent of the morphologic appearance of the chorionic villi. Am J Surg Pathol 2020; 44(6):849-58. Pubmed ID:32205485
  10. Hoyos LR, Cheng CY, Brennan K, Hubert G, Wang B, Buyalos RP, Quinn M, Shamonki M. Euploid rates among oocyte donors: is there an optimal age for donation? J Assist Reprod Genet 2020; 37(3):589-94. Pubmed ID:31955339
  11. Quinn MM, Rosen MP, Allen IE, Huddleston HG, Cedars MI, Fujimoto VY. Interpregnancy interval and singleton pregnancy outcomes following frozen embryo transfer. Fertil Steril 2019; 111(6):1145-50. Pubmed ID:30955846
  12. Quinn MM, Juarez-Hernandez F, Dunn M, Okamura RJ, Cedars MI, Rosen MP. Decision-making surrounding the use of preimplantation genetic testing for aneuploidy reveals misunderstanding regarding its benefit. J Assist Reprod Genet 2018; Pubmed ID:30334131
  13. Quinn MM, Rosen MP, Allen IE, Huddleston HG, Cedars MI, Fujimoto VY. Decreased clinical pregnancy and live birth rates after short interval from delivery to subsequent assisted reproduction attempt. Hum Reprod 2018; 33(7):1316-21. Pubmed ID:29912323
  14. Quinn MM, Rosen MP, Huddleston HG, Cedars MI, Fujimoto VY. Interpregnancy interval and singleton live birth outcomes from in vitro fertilization. Obstet Gynecol 2018; 132(1):115-21. Pubmed ID:29889753
  15. Quinn MM, Jalalian L, Ribeiro S, Ona K, Demirci U, Cedars MI, Rosen MP. Microfluidic sorting selects sperm for clinical use with reduced DNA damage compared to density-gradient centrifugation with swim-up in split semen samples. Hum Reprod 2018; 33(8):1388-93. Pubmed ID: 30007319
  16. Quinn MM and Cedars MI. Cardiovascular health and ovarian aging. Fertil Steril 2018; 110(5):790-3. Pubmed ID: 30316413
  17. Turan V, Quinn MM, Karadayi N, Rosen MP, Oktay K. The impact of malignancy on response to ovarian stimulation for fertility preservation: A meta-analysis. Fertil Steril 2018; 110:1347-55.
  18. Quinn MM and Cedars MI. Declining fertility with reproductive aging: how to protect your patient’s fertility by knowing the milestones. Obstet Gynecol Clin North Am 2018; 45(4):575-83. Pubmed iD:30401543
  19. Ahmad AK, Kao C, Quinn M, Lenhart N, Rosen M, Cedars MI, Huddleston H. Differential rate of decline in ovarian reserve markers in polycystic ovary syndrome compared to controls: Results of a longitudinal study. Fertil Steril 2018;109(3):526-31. Pubmed ID: 29428308
  20. Quinn MM, Kao CN, Ahmad AK, Haisenleder DH, Santoro N, Eisenberg E, Legro RS, Cedars MI, Huddleston HG. Age-stratified thresholds of anti-Mullerian hormone improve prediction of polycystic ovary syndrome over a population-based threshold. Clin Endocrinol 2017; 87(6):733-40. Pubmed ID:28681949
  21. Quinn MM and Cedars MI. A canary in the coal mine: Reproductive health and cardiovascular disease in women. Semin Reprod Med 2017 35(3):250-255. Pubmed ID: 28658708
  22. Quinn MM, Cakmak H, Letourneau JM, Cedars MI, Rosen MP. Response to controlled ovarian stimulation is not impacted by a breast cancer diagnosis. Hum Reprod 2017;32(3):568-74. Pubmed ID:28122888
  23. Huddleston HG, Quinn MM, Kao CN, Lenhart N, Rosen MP, Cedars MI. Women with polycystic ovary syndrome demonstrate worsening markers of cardiovascular risk over the short-term despite declining hyperandrogenemia: Results of a longitudinal study with community controls. Clin Endo 2017; 87(6):775-82. Pubmed ID: 29044581
  24. Letourneau JM, Cakmak H, Quinn MM, Sinha N, Cedars MI, Rosen MP. Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield. J Assist Reprod Genet 2017;34(9):1137-44. Pubmed ID: 28669055
  25. Letourneau JM, Sinha N, Wald K, Harris E, Quinn M, Mok-Lin E, Chien J, Rosen M. Random start ovarian stimulation for fertility preservation does not delay initiation of neoadjuvant chemotherapy for breast cancer. Hum Reprod 2017;32:2123-29. Pubmed ID: 28938748
  26. Quinn MM, Kao C, Ahmad A, Lenhart N, Shinkai K, Cedars MI, Huddleston HG. Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk Fertil Steril 2016; 106(5):1244-51. Pubmed ID:27445197
  27. Quinn M and Fujimoto VY. Racial and ethnic disparities in assisted reproductive technology access and outcomes. Fertil Steril 2016;105(5):1119-23. Pubmed ID: 27054308
  28. Quinn M, Shinkai K, Pasch L, Kuzmich L, Cedars M, Huddleston H. Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features. Fertil Steril 2014; 101(4):1129-34. Pubmed ID: 24534277
  29. Quinn MM, Letourneau J, Rosen M. Contraception after cancer treatment: Describing methods, counseling and unintended pregnancy risk. Contraception 2014;89:466-71. Pubmed ID:24576795
  30. Cooper C, Calligaro G, Quinn M, Eshaghian P, Coskun F, Abrazado M et al. Determinants of dynamic hyperinflation during metronome-paced tachypnea in COPD and normal subjects. Resp Phys 2014; 190:76-80. Pubmed ID:23994176
  31. Amin S, Abrazado M, Quinn M, Storer T, Tseng C, Cooper C. A controlled study of community-based exercise training in patient with moderate COPD. BMC Pulmonary Medicine 2014; 14:125. Pubmed ID:25088030
  32. Mindry D, Wagner G, Lake J, Smith A, Linnemayr S, Quinn M, Hoffman R. Fertility desires among HIV-infected men and women in Los Angeles County: Client needs and provider perspectives. Matern Child Health J 2013; 17(4):593-600. Pubmed ID:22562286
  33. Novak SH, Quinn M, Canan T, Metten S, Wisco JJ, Wimmers PF, Uijtdehaage S. A new approach to learning how to teach: medical students as instructional designers. Med Educ Online 2011;16. Pubmed ID:21776188

Book Chapters

  1. Gibson M, Quinn MM, Huddleston HG (2019). Part XXIV, Chapter 567. Polycystic Ovary Syndrome and Hirsutism. In RM Kliegman and JW St. Geme (Eds.), Nelson Textbook of Pediatrics, 21st Atlanta, GA: Elsevier.
  2. Rosen M, Yang X, Marsh P, Runge A, Olivera G, Ribeiro S, Simbulan R, Quinn M. (2018). Chapter 32. Gamete and Embryo Manipulation. In Strauss J and Barbieri R (Eds.), Yen & Jaffe’s Reproductive Endocrinology, 8th Edition (pp.823-56). Atlanta, GA: Elsevier.
  3. Quinn MM and Huddleston HG (2017). Gestational Surrogacy. In LC Giudice and C Simon (Eds.), The Endometrial Factor: A Reproductive Precision Medicine Approach (pp. 228-33). Boca Raton, FL: CRC Press.
  4. Quinn M. Agile Diagnosis. Interactive Clinical Guidelines: Primary Amenorrhea and Secondary Amenorrhea. 2012.

Abstracts/National Presentations

  1. Douglas C, Dilday E, Quinn MM. Fertility preservation outcomes in transgender men on testosterone therapy. Oral Presentation at 2021 American Society of Reproductive Medicine Annual Conference. October 2021, Baltimore, MD.
  2. Hariton E, Morris J, Kao, CN, Jaswa EG, Quinn MM, Cedars MI, Huddleston HG. An AMH-based screening tool is both sensitive and specific for a diagnosis of PCOS by Rotterdam Criteria. Oral Presentation at: 2020 American Society of Reproductive Medicine Annual Conference. October 2020, Virtual conference.
  3. Riestenberg C, Quinn MM, Akopians A, Danzer H, Surrey S, Ghadir S, Kroener L. Endometrial compaction does not predict ongoing pregnancy rate in programmed single euploid embryo transfer cycles. Poster Presentation. American Society for Reproductive Medicine Annual Conference. October 2020, Virtual Conference.
  4. Riestenberg C, Quinn MM, Akopians A, Danzer H, Surrey S, Ghadir S, Kroener L. Endometrial compaction does not predict ongoing pregnancy rate in programmed single euploid embryo transfer cycles. Poster Presentation. American Society for Reproductive Medicine Annual Conference. October 2020, Virtual Conference.
  5. Dilday EA, Hoyos LR, Quinn MM, Kroener LL. Luteal phase support with progesterone does not improve pregnancy rates in patients undergoing controlled ovarian stimulation with letrozole. Poster Presentation. American Society for Reproductive Medicine Annual Conference. October 2020, Virtual Conference.
  6. Mehr H, Jackson-Bey T, Vu M, Lee V, Herndon C, Ho J, Aghajanova L, Quinn MM. We are here for you: Infertility clinic website communication during the escalating stages of the COVID-19 pandemic. Poster Presentation. American Society for Reproductive Medicine Annual Conference. October 2020, Virtual Conference.
  7. Hariton E, Morris J, Kao C-N, Jaswa E, Quinn MM, Cedars MI, Huddleston HG. An AMH-based screening tool is both sensitive and specific for predicting a diagnosis of PCOS by Rotterdam Criteria. Oral Presentation. American Society for Reproductive Medicine Annual Conference. October 2020, Virtual Conference.
  8. Mehr H, Lee V, Jackson-Bey T, Herndon C, Quinn MM. Reading level of patient education material on infertility clinic websites is above national recommendations. Oral Presentation. American Society for Reproductive Medicine Annual Conference. October 2020, Virtual Conference.
  9. Shapiro AJ and Quinn MM. Patient experience with expanded-carrier screening: adequacy of provider counseling, economic burden and decision-making regarding partner testing. Oral Presentation. American Society for Reproductive Medicine Annual Conference. October 2020, Virtual Conference.
  10. Riestenberg C, Moyle K, Silverman N, Plann LD, Han CS, Quinn MM. Sonographic abnormalities in pregnancies conceived following IVF with and without preimplantation genetic testing for aneuploidy. Oral Presentation. American Society for Reproductive Medicine Annual Conference. October 2019, Philadelphia, PA.
  11. Wijekoon A, Rosen MP, Quinn MM. Lessons learned from evaluating decisional regret surrounding preimplantation genetic testing for aneuploidy. Oral Presentation. American Society for Reproductive Medicine Annual Conference. October 2019, Philadelphia, PA.
  12. Vyas N, Singer A, Ter-Narsegyan A, Kantor A, Mann C, Lambrechts SI, Quinn MM. Reproductive life planning and interest in fertility preservation among transgender and gender non-binary individuals. Oral Presentation. American Society for Reproductive Medicine Annual Conference. October 2019, Philadelphia PA.
  13. Jackson-Bey T, Mehr H, Ho J, Aghajanova L, Quinn MM, Hoffman JR, Herndon CN. Nationwide survey of access to care initiatives in REI practices associated with OB/GYN residency programs. Poster Presentation. American Society for Reproductive Medicine Annual Conference. October 2019, Philadelphia PA.
  14. Hoyos LR, Cheng CY, Riestenberg C, Armstrong AA, Quinn MM. Impact of obesity on oocyte cryosurvival after vitrification. Poster Presentation. Poster Presentation. American Society for Reproductive Medicine Annual Conference. October 2019, Philadelphia PA.
  15. Patel H, Zore T, Buyalos R, Hubert G, Wang C, Brower M, Shamonki M, Quinn MM. Effect of estrogen to progesterone ratio at time of ovulation trigger on subsequent euploid frozen embryo transfer pregnancy rate. Poster Presentation. American Society for Reproductive Medicine Annual Conference. October 2019, Philadelphia PA.
  16. Mehr H, Shamonki M, Wang C, Buyalos R, Hubert G, Quinn MM. Does universal screening for chronic endometritis improve pregnancy rates? Poster Presentation. American Society for Reproductive Medicine Annual Conference. October 2019, Philadelphia PA.
  17. Shapiro AJ, Quinn MM. Expanded carrier screening for recessively inherited genetic disorders: Factors in decision-making when one individual in a couple is identified as a carrier. Poster Presentation. American Society for Reproductive Medicine Annual Conference. October 2019, Philadelphia PA.
  18. Huang D, Greenwood EA, Kao CN, Quinn MM, Cedars MI, Huddleston HG. Prevalence and predictors of adequate physical activity in a multiethnic polycystic ovary syndrome patient population. Poster Presentation. American Society for Reproductive Medicine Annual Conference. October 2019, Philadelphia PA.
  19. Huang D, Greenwood EA, Kao CN, Quinn MM, Cedars MI, Huddleston HG. Prevalence and predictors of adequate physical activity in a multiethnic polycystic ovary syndrome patient population. Poster Presentation. American Society for Reproductive Medicine Annual Conference. October 2019, Philadelphia PA.
  20. Mehr H, Jackson-Bey T, Ho J, Aghajanova L, Quinn MM, Hoffman JR, Herndon CN. Clinical exposure in OB/GYN resident training programs in the United States to infertility care for low resource and undeserved communities. Poster Presentation. American Society for Reproductive Medicine Annual Conference. October 2019, Philadelphia PA.
  21. Quinn MM, Juarez-Hernandez F, Dunn M, Okamura RJ, Cedars MI, Rosen MP. Decision-making surrounding the use of preimplantation genetic testing for aneuploidy reveals misunderstanding regarding its benefit. Poster Presentation. American Society for Reproductive Medicine Annual Conference. October 2018, Denver, CO.
  22. Quinn MM, Huddleston HG, Rosen MP, Cedars MI, Fujimoto VY. Short interpregnancy interval (IPI) is associated with preterm delivery in singleton live births from a national cohort undergoing assisted reproductive technology (ART). Oral Presentation. American Society for Reproductive Medicine Annual Conference. ASRM Prize Paper Candidate. October 2017, San Antonio, TX.
  23. Quinn MM, Rosen MP, Huddleston HG, Cedars MI, Fujimoto VY. Decreased clinical pregnancy and live birth rates after short interval from delivery to subsequent assisted reproduction attempt: An analysis of 51,997 Society for Assisted Reproductive Technology (SART) Cycles. Oral Presentation. American Society for Reproductive Medicine Annual Conference. SART Prize Paper Winner. October 2017, San Antonio, TX.
  24. Quinn MM, Chinnasamy T, Miansarigavzan M, Jalalian L, Demirci U, Rosen MP. Microfluidic sorting selects sperm for clinical use with reduced DNA damage compared to density gradient centrifugation in split semen samples. Oral Presentation. American Society for Reproductive Medicine Annual Conference. October 2017, San Antonio, TX.
  25. Quinn MM, Noel MW, Cedars MI, Huddleston HG. Genetic testing of products of conception for spontaneous miscarriage: Prognosis for subsequent pregnancy and live birth. Pacific Coast Reproductive Society Annual Conference. March 2017, Indian Wells, CA.
  26. Quinn MM, Gerona RR, Cedars MI. Bisphenol A exposure is not associated with longitudinal change in ovarian reserve parameters. Oral Presentation. American Society of Reproductive Medicine Annual Conference. October 2016, Salt Lake City UT.
  27. Quinn MM, Cedars MI, Fujimoto VY. Short interpregnancy interval and obstetric outcomes in assisted reproduction. Poster Presentation. American Society of Reproductive Medicine Annual Conference. October 2016, Salt Lake City UT.
  28. Quinn MM, Kao C, Ahmad AK, Cedars MI, Santoro N, Eisenberg E, Haisenleder DJ, Legro RS, Huddleston HG. Anti-mullerian hormone (AMH) as a predictor of polycystic ovary syndrome (PCOS): Age and Body Mass Index (BMI)-stratified thresholds for distinguishing PCOS from controls using an identical assay. Poster Presentation. American Society of Reproductive Medicine Annual Conference. October 2016, Salt Lake City UT.
  29. Quinn MM, Cakmak H, Letourneau J, Cedars MI, Rosen MP. Cancer diagnosis is associated with equivalent ovarian reserve, response to ovarian stimulation and fertility preservation outcome when compared to elective oocyte cryopreservation. Poster Presentation. American Society of Reproductive Medicine Annual Conference. October 2016, Salt Lake City UT.
  30. Quinn MM, Cakmak H, Letourneau J, Cedars MI, Rosen MP. Titration of letrozole to maintain low estradiol levels during fertility preservation cycles for estrogen receptor positive breast cancer patients does not impact ovarian response or mature oocyte yield. Poster Presentation. American Society of Reproductive Medicine Annual Conference. October 2016, Salt Lake City UT.
  31. Quinn MM, Tran ND, Fujimoto VY. Norethindrone priming prior to gonadotropin-releasing hormone (GnRH) antagonist protocol produces equivalent outcomes to estradiol (E2) priming protocol. Poster Presentation. Society for Gynecologic Investigation. March 19 2016, Montreal Canada.
  32. Quinn MM, Cedars MI, Shinkai K, Pasch LA, Huddleston HG. Raising threshold for diagnosis of polycystic ovary syndrome (PCOS) misses population of patients at risk for metabolic dysfunction. Oral Presentation. Androgen Excess & Polycystic Ovary Syndrome Society Annual Meeting. October 23 2014, Kauai HI.
  33. Quinn MM, Pasch LA, Shinkai K, Cedars MI, Huddleston HG. Ovarian volume as a non-linear predictor of metabolic dysfunction in polycystic ovary syndrome (PCOS). Poster Presentation. Androgen Excess & Polycystic Ovary Syndrome Society Annual Meeting. October 23 2014, Kauai HI.
  34. Quinn M, Shinkai K, Pasch L, Kuzmich L, Cedars M, Huddleston H. Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features. Oral Presentation. American Society of Reproductive Medicine Annual Conference. Oct 14 2013, Boston MA.
  35. Quinn M, Eshaghian P, Coskun F, Raine RI, Bateman E, Cooper C. Metronome-paced tachypnea for measurement of dynamic hyperinflation in COPD patients and normal controls. Poster Presentation UCLA Department of Medicine Research Day October 2008, Los Angeles CA and American Thoracic Society International Conference. May 18 2009, San Diego CA.
  36. Moscato M and Quinn M. Case of Anti-NMDA Receptor Encephalitis and Treatment Decisions. Poster Presentation UCLA Department of Neurology Alumni Day Neurology and Neuroscience Trainee Poster Presentation May 26 2010, Los Angeles CA.
  37. Amin S, Quinn M, Abrazado M, Forster R, Berenc M, Storer T, Cooper C. Controlled Feasibility of a Community-Based Exercise Program in Patients with Moderate COPD. Poster Presentation. American Thoracic Society International Conference. May 17 2011, Colorado Convention Center.
HRC Fertility - Pasadena, California

HRC Fertility – Pasadena

55 S. Lake Ave, 9th Fl.
Pasadena, CA 91101

Current Patients: 626-440-9161